Hypermarcas (OTCMKTS:HYPMY) Shares Cross Above 50-Day Moving Average - Here's Why

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $4.13 and traded as high as $5.07. Hypermarcas shares last traded at $4.95, with a volume of 773,806 shares.

Hypermarcas Trading Down 1.8%

The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. The firm has a market capitalization of $3.08 billion, a PE ratio of 20.23 and a beta of 0.79. The business's 50-day moving average price is $4.20 and its 200-day moving average price is $3.56.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $184.34 million for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.